Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO: 4502) (NYSE: TAK) (“Takeda”) today announced financial results for the year ended March...






